
The global Personal Genome Testing market size was valued at US$ 1756.7 million in 2023. With growing demand in downstream market, the Personal Genome Testing is forecast to a readjusted size of US$ 3174 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global Personal Genome Testing market. Personal Genome Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personal Genome Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personal Genome Testing market.
Key Features:
The report on Personal Genome Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personal Genome Testing market. It may include historical data, market segmentation by Type (e.g., Targeted Testing, Non-Targeted Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personal Genome Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personal Genome Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personal Genome Testing industry. This include advancements in Personal Genome Testing technology, Personal Genome Testing new entrants, Personal Genome Testing new investment, and other innovations that are shaping the future of Personal Genome Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personal Genome Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Personal Genome Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personal Genome Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personal Genome Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personal Genome Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personal Genome Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personal Genome Testing market.
Market Segmentation:
Personal Genome Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Segmentation by application
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personal Genome Testing Market Size 2019-2030
2.1.2 Personal Genome Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personal Genome Testing Segment by Type
2.2.1 Targeted Testing
2.2.2 Non-Targeted Testing
2.2.3 Multi-Targeted Testing
2.3 Personal Genome Testing Market Size by Type
2.3.1 Personal Genome Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personal Genome Testing Market Size Market Share by Type (2019-2024)
2.4 Personal Genome Testing Segment by Application
2.4.1 Neurological Disorders
2.4.2 Oncology
2.4.3 Metabolic Disorders
2.4.4 Autoimmune Disorders
2.4.5 Others
2.5 Personal Genome Testing Market Size by Application
2.5.1 Personal Genome Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personal Genome Testing Market Size Market Share by Application (2019-2024)
3 Personal Genome Testing Market Size by Player
3.1 Personal Genome Testing Market Size Market Share by Players
3.1.1 Global Personal Genome Testing Revenue by Players (2019-2024)
3.1.2 Global Personal Genome Testing Revenue Market Share by Players (2019-2024)
3.2 Global Personal Genome Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Personal Genome Testing by Regions
4.1 Personal Genome Testing Market Size by Regions (2019-2024)
4.2 Americas Personal Genome Testing Market Size Growth (2019-2024)
4.3 APAC Personal Genome Testing Market Size Growth (2019-2024)
4.4 Europe Personal Genome Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Personal Genome Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Personal Genome Testing Market Size by Country (2019-2024)
5.2 Americas Personal Genome Testing Market Size by Type (2019-2024)
5.3 Americas Personal Genome Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personal Genome Testing Market Size by Region (2019-2024)
6.2 APAC Personal Genome Testing Market Size by Type (2019-2024)
6.3 APAC Personal Genome Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Personal Genome Testing by Country (2019-2024)
7.2 Europe Personal Genome Testing Market Size by Type (2019-2024)
7.3 Europe Personal Genome Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Personal Genome Testing by Region (2019-2024)
8.2 Middle East & Africa Personal Genome Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Personal Genome Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Personal Genome Testing Market Forecast
10.1 Global Personal Genome Testing Forecast by Regions (2025-2030)
10.1.1 Global Personal Genome Testing Forecast by Regions (2025-2030)
10.1.2 Americas Personal Genome Testing Forecast
10.1.3 APAC Personal Genome Testing Forecast
10.1.4 Europe Personal Genome Testing Forecast
10.1.5 Middle East & Africa Personal Genome Testing Forecast
10.2 Americas Personal Genome Testing Forecast by Country (2025-2030)
10.2.1 United States Personal Genome Testing Market Forecast
10.2.2 Canada Personal Genome Testing Market Forecast
10.2.3 Mexico Personal Genome Testing Market Forecast
10.2.4 Brazil Personal Genome Testing Market Forecast
10.3 APAC Personal Genome Testing Forecast by Region (2025-2030)
10.3.1 China Personal Genome Testing Market Forecast
10.3.2 Japan Personal Genome Testing Market Forecast
10.3.3 Korea Personal Genome Testing Market Forecast
10.3.4 Southeast Asia Personal Genome Testing Market Forecast
10.3.5 India Personal Genome Testing Market Forecast
10.3.6 Australia Personal Genome Testing Market Forecast
10.4 Europe Personal Genome Testing Forecast by Country (2025-2030)
10.4.1 Germany Personal Genome Testing Market Forecast
10.4.2 France Personal Genome Testing Market Forecast
10.4.3 UK Personal Genome Testing Market Forecast
10.4.4 Italy Personal Genome Testing Market Forecast
10.4.5 Russia Personal Genome Testing Market Forecast
10.5 Middle East & Africa Personal Genome Testing Forecast by Region (2025-2030)
10.5.1 Egypt Personal Genome Testing Market Forecast
10.5.2 South Africa Personal Genome Testing Market Forecast
10.5.3 Israel Personal Genome Testing Market Forecast
10.5.4 Turkey Personal Genome Testing Market Forecast
10.5.5 GCC Countries Personal Genome Testing Market Forecast
10.6 Global Personal Genome Testing Forecast by Type (2025-2030)
10.7 Global Personal Genome Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Information
11.1.2 23andMe, Inc. Personal Genome Testing Product Offered
11.1.3 23andMe, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 23andMe, Inc. Main Business Overview
11.1.5 23andMe, Inc. Latest Developments
11.2 Navigenics
11.2.1 Navigenics Company Information
11.2.2 Navigenics Personal Genome Testing Product Offered
11.2.3 Navigenics Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Navigenics Main Business Overview
11.2.5 Navigenics Latest Developments
11.3 deCODEme
11.3.1 deCODEme Company Information
11.3.2 deCODEme Personal Genome Testing Product Offered
11.3.3 deCODEme Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 deCODEme Main Business Overview
11.3.5 deCODEme Latest Developments
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Information
11.4.2 Color Genomics, Inc. Personal Genome Testing Product Offered
11.4.3 Color Genomics, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Color Genomics, Inc. Main Business Overview
11.4.5 Color Genomics, Inc. Latest Developments
11.5 Personal Genome Diagnostics, Inc.
11.5.1 Personal Genome Diagnostics, Inc. Company Information
11.5.2 Personal Genome Diagnostics, Inc. Personal Genome Testing Product Offered
11.5.3 Personal Genome Diagnostics, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Personal Genome Diagnostics, Inc. Main Business Overview
11.5.5 Personal Genome Diagnostics, Inc. Latest Developments
11.6 Counsyl, Inc.
11.6.1 Counsyl, Inc. Company Information
11.6.2 Counsyl, Inc. Personal Genome Testing Product Offered
11.6.3 Counsyl, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Counsyl, Inc. Main Business Overview
11.6.5 Counsyl, Inc. Latest Developments
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Information
11.7.2 Quest Diagnostics Personal Genome Testing Product Offered
11.7.3 Quest Diagnostics Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Quest Diagnostics Main Business Overview
11.7.5 Quest Diagnostics Latest Developments
11.8 Gene By Gene, Ltd.
11.8.1 Gene By Gene, Ltd. Company Information
11.8.2 Gene By Gene, Ltd. Personal Genome Testing Product Offered
11.8.3 Gene By Gene, Ltd. Personal Genome Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Gene By Gene, Ltd. Main Business Overview
11.8.5 Gene By Gene, Ltd. Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
